5.64BMarket Cap191.59P/E (TTM)
18.000High16.770Low17.33KVolume18.000Open16.780Pre Close294.59KTurnover0.10%Turnover Ratio1873.33P/E (Static)334.72MShares19.99052wk High22.27P/B286.62MFloat Cap14.01052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM7.33%Amplitude14.010Historical Low17.003Avg Price1Lot Size
Telix Pharmaceuticals Stock Forum
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Positive
Strategic acquisition of next-generation therapeutic pipeline and technology platform
Access to state-of-the-art California research facility and expert team
Enhanced in-house capabilities in antibody engineering
Technology enables highly specific cancer targeting with improved efficiency
Potential for expansion into new therapy areas
Negative
Significant upf...
No comment yet